Products Categories
CAS No.: | 116539-59-4 |
---|---|
Name: | Duloxetine |
Article Data: | 62 |
Molecular Structure: | |
Formula: | C18H19NOS |
Molecular Weight: | 297.421 |
Synonyms: | 2-Thiophenepropanamine,N-methyl-g-(1-naphthalenyloxy)-, (S)-;(S)-Duloxetine;LY 248686;Yentreve;Duloxetine Boehringer Ingelheim;Ariclaim; |
EINECS: | 601-438-0 |
Density: | 1.158 g/cm3 |
Boiling Point: | 466.2 °C at 760 mmHg |
Flash Point: | 235.7 °C |
PSA: | 49.50000 |
LogP: | 5.82380 |
IUPAC Name: (3S)-N-Methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine
Following is the structure of 2-Thiophenepropanamine,N-methyl-g-(1-naphthalenyloxy)-, (gS)- (CAS NO.116539-59-4):
Empirical Formula: C18H19NOS
Molecular Weight: 297.4146
Index of Refraction: 1.627
Molar Refractivity: 91.14 cm3
Molar Volume: 256.8 cm3
Polarizability: 36.13 10-24cm3
Density: 1.158 g/cm3
Flash Point: 235.7 °C
Surface Tension: 46 dyne/cm
Enthalpy of Vaporization: 72.79 kJ/mol
Boiling Point: 466.2 °C at 760 mmHg
Vapour Pressure: 7.23E-09 mmHg at 25 °C
Product Categories of 2-Thiophenepropanamine,N-methyl-g-(1-naphthalenyloxy)-, (gS)- (CAS NO.116539-59-4): ACTIVE PHARMACEUTICAL INGREDIENTS
Canonical SMILES: CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
Isomeric SMILES: CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
InChI: InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1
InChIKey: ZEUITGRIYCTCEM-KRWDZBQOSA-N
2-Thiophenepropanamine,N-methyl-g-(1-naphthalenyloxy)-, (gS)- , its cas register number 116539-59-4. It also can be called (S)-Duloxetine ; (S)-N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine ; Ariclaim ; Cymbalta ; Duloxetine ; Duloxetine Boehringer Ingelheim ; Xeristar ; and Yentreve . Its classification code are Adrenergic Agents; Adrenergic Uptake Inhibitors; Antidepressant; Antidepressive Agents; Central Nervous System Agents; Dopamine Agents; Dopamine Uptake Inhibitors; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Psychotropic Drugs; Serotonin Agents and Serotonin Uptake Inhibitors.